Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway

Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway

Humoral immunity to factor VIII (FVIII) represents a significant challenge for the treatment of patients with hemophilia A. Current paradigms indicate that neutralizing antibodies against FVIII (inhibitors) occur through a classical CD4 T cell, germinal center (GC) dependent process. However, clinic...

Full description

Bibliographic Details
Main Authors: Seema R. Patel, Taran S. Lundgren, Wallace Hunter Baldwin, Courtney Cox, Ernest T. Parker, John F. Healey, Ryan P. Jajosky, Patricia E. Zerra, Cassandra D. Josephson, Christopher B. Doering, Sean R. Stowell, Shannon L. Meeks
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Immunology
Subjects:
hemophilia A
germinal center
B cells
neutralizing antibodies (inhibitors)
extrafollicular pathway
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.880829/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.880829/full

Similar Items